Results 91 to 100 of about 16,043 (285)

Practical Considerations for Managing Patients on Tyvaso DPI (Treprostinil Inhalation Powder)

Pulmonary Circulation, Volume 15, Issue 3, July 2025.
ABSTRACT Pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH‐ILD) require a multifaceted, guideline‐directed management approach. This includes active patient participation in partnership with their healthcare team to minimize disease impact and improve survival.
Jennifer H. Keeley, Jacqueline Skarre, Lori Reed, Loida A. Johnson, Catherine Falardeau, Brittany N. J. Davis, Manisit Das, Howard Castillo, Susanne McDevitt   +8 more
wiley   +1 more source

A Comparison of the efficacy of cetirizine and terfenadine in chronic idiopathic urticaria

Indian Journal of Dermatology, 1996
: In a 10 d, double blind, randomized, parallel study, the efficacy of cetirizine and terfenadine was compared in 30 patients with chronic idiopathic urticaria. Subjects were randomly divided into two patient groups of 15 each.
Chatterjee G, Banerjee PK
doaj  

Expert Consensus on the Clinical Application of PI3K/AKT/mTOR Inhibitors in the Treatment of Breast Cancer (2025 Edition)

Cancer Innovation, Volume 4, Issue 3, June 2025.
ABSTRACT Background The phosphoinositide 3‐kinase (PI3K)/protein kinase B (PKB or AKT)/mammalian target of rapamycin (mTOR) signaling pathway (PAM pathway) plays a critical role in breast cancer pathogenesis and progression, and is closely linked with resistance to endocrine therapy in advanced breast cancer.
The Breast Cancer Expert Committee of the National Quality Control Center for Cancer, The Expert Committee on Cancer Prevention and Treatment of the Health China Research Center, The Society of Clinical Research on Oncology Medications of the China Anti‐Cancer Association, The Society of Onco‐Pathology of the China Anti‐Cancer Association   +3 more
wiley   +1 more source

Wernicke Encephalopathy in a Child With Acute Lymphoblastic Leukemia: A Case Report

Cancer Reports, Volume 8, Issue 6, June 2025.
ABSTRACT Background Wernicke encephalopathy (WE) is a life‐threatening neurological disorder caused by thiamine deficiency, commonly associated with alcoholism but also observed in malnourished pediatric cancer patients undergoing intensive chemotherapy. WE remains underdiagnosed in children, with many cases only confirmed postmortem.
Ghazaleh Shakibamaram, Mohammadreza Dolikhani, Farideh Moussavi, Syna Sarraf, Bredsin Benyamin, Soroor Advani   +5 more
wiley   +1 more source

APPLICATION EXPERIENCE OF CETIRIZINE SYRUP IN THE TREATMENT OF ATOPIC DERMATITIS AMONG CHILDREN

Педиатрическая фармакология, 2007
The article gives the findings of the scientific research, whose purpose was to study the impact of cetirizine syrup (Zodiac, Zentiva, Czech Republic) on the run of atopic dermatitis among 36 children aged between 2 and 6 years old.
I.V. Makarova, R.N. Arakelyan, N.B. Bal'tserovich, S.G. Lazareva, E.V. Mukharaeva   +4 more
doaj   +2 more sources

Faster onset of action with topical levocabastine than with oral cetirizine

Mediators of Inflammation, 1995
This international multicentre, open-label, parallel-group trial was undertaken to compare the therapeutic efficacy and tolerability of topical levocabastine and oral cetirizine in patients with perennial allergic rhinoconjunctivitis, with particular ...
Michel A. Drouin, William H. Yang, Frederick Horak   +2 more
doaj   +1 more source

Fexofenadine is Efficacious and Safe in Children (Aged 6-11 Years) with Seasonal Allergic Rhinitis [PDF]

, 2003
Background: This is the first prospective, randomized, doubleblind, placebo-controlled study showing statistical improvement of an H1-antihistamine in children with seasonal allergic rhinitis in all symptoms throughout the entire treatment period ...
Bachert, C, Baena-Cagnani, C, Decosta, P, Finn, A, Hedlin, G, Kowalski, M, Meltzer, E, Potter, P, Rosado-Pinto, J, Ruuth, E, Scheinmann, P, Simons, F, Wahn, U   +12 more
core  

Efficacy of a Tumor Necrosis Factor Inhibitor in Chronic Low‐Back Pain With Modic Type 1 Changes: A Randomized Controlled Trial

Arthritis &Rheumatology, Volume 77, Issue 5, Page 615-623, May 2025.
Efficacy of a Tumor necrosis inhibitor in chronic low‐back pain with Modic type 1 changes: The BackToBasic study, A randomized controlled trial. Objective The efficacy of tumor necrosis factor inhibitors for treating chronic low‐back pain with Modic changes is uncertain.
Elisabeth Gjefsen, Lars C. Bråten, Erica Ponzi, Magnhild H. Dagestad, Gunn H. Marchand, Thomas Kadar, Gunnstein Bakland, Anne J. Haugen, Fredrik Granviken, Tonje W. Flørenes, Nils Vetti, Lars Grøvle, Aksel T. Nilsen, Astrid Lunestad, Thor E. Holmgard, Morten Valberg, Nils Bolstad, Ansgar Espeland, Jens I. Brox, Guro L. Goll, Kjersti Storheim, John‐Anker Zwart   +21 more
wiley   +1 more source

Rationale for selecting antihistamine drugs for the therapy of chronic urticaria in terms of efficacy and safety

Vestnik Dermatologii i Venerologii, 2017
Goal of the study. To compare the efficacy of antihistamine drugs for the therapy of chronic urticaria taking into consideration their effect on the patients’ cognitive functions. Materials and methods.
O. V. Skorokhodkina, S. V. Klyucharyova
doaj   +1 more source

First- or second-generation antihistamines: which are more effective at controlling pruritus? [PDF]

, 2004
For urticarial itch, first- and second-generation antihistamines have similar clinical benefit and are superior to placebo (strength of recommendation [SOR]: A, systematic review of randomized trials [RCT]).
Crownover, Brian K., Jamieson, Barbara
core